Effect of antidepressant treatment on peripheral inflammation markers - A meta-analysis - PubMed
- ️Mon Jan 01 2018
Meta-Analysis
. 2018 Jan 3;80(Pt C):217-226.
doi: 10.1016/j.pnpbp.2017.04.026. Epub 2017 Apr 23.
Affiliations
- PMID: 28445690
- DOI: 10.1016/j.pnpbp.2017.04.026
Meta-Analysis
Effect of antidepressant treatment on peripheral inflammation markers - A meta-analysis
Magdalena Więdłocha et al. Prog Neuropsychopharmacol Biol Psychiatry. 2018.
Abstract
Introduction: Major Depressive Disorder (MDD) in accordance to the inflammatory concept is associated with complex immunological disturbances in the central nervous system (CNS). This is reflected by elevated plasma levels of inflammatory cytokines in depressed subjects. Although numerous studies report significant influence of antidepressants on pro-inflammatory/anti-inflammatory cytokines balance, the available data is often inconsistent regarding specific cytokines and drugs used. We aimed to perform a comprehensive meta-analysis of the effect of antidepressant treatment on a wide array of cytokines.
Methods: We performed a systematic search of 6 databases, which yielded 32 studies measuring the levels of selected cytokines before and at a second time-point during antidepressant treatment. For meta-analysis of selected studies with a continuous measure we analysed variables containing the number of cases, mean and standard deviation of the level of IL-1ß, IL-2, IL-5, IL-6, IL-8, IL-10, CRP, TNF-α, IFN-γ levels observed in the different studies, in the intervention groups before and after antidepressant treatment.
Results: Statistical analysis revealed significant decreases of IL-4, IL-6, and IL-10 in MDD subjects after antidepressant treatment. In case of IL-1ß the decrease was significant exclusively for SSRI drugs. We did not find any significant effect of antidepressant medication on IL-2, TNF-α IFN-γ and CRP.
Conclusions: Antidepressant treatment affects the levels of cytokines in depression. The immunological imbalance in MDD is complex and seems to be mediated by other factors yet to be elucidated. The credibility of our results is limited by high heterogeneity among studies and very few studies with a placebo-controlled design. Research with MDD subtypes, response to treatment status and cytokine associations with the kynurenine pathway taken into account pose a promising target for future studies.
Keywords: Antidepressants; Cytokines; Depression; Inflammation; Meta-analysis.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
Hannestad J, DellaGioia N, Bloch M. Hannestad J, et al. Neuropsychopharmacology. 2011 Nov;36(12):2452-9. doi: 10.1038/npp.2011.132. Epub 2011 Jul 27. Neuropsychopharmacology. 2011. PMID: 21796103 Free PMC article.
-
Liu JJ, Wei YB, Strawbridge R, Bao Y, Chang S, Shi L, Que J, Gadad BS, Trivedi MH, Kelsoe JR, Lu L. Liu JJ, et al. Mol Psychiatry. 2020 Feb;25(2):339-350. doi: 10.1038/s41380-019-0474-5. Epub 2019 Aug 19. Mol Psychiatry. 2020. PMID: 31427752
-
Schmidt FM, Schröder T, Kirkby KC, Sander C, Suslow T, Holdt LM, Teupser D, Hegerl U, Himmerich H. Schmidt FM, et al. Psychiatry Res. 2016 May 30;239:85-91. doi: 10.1016/j.psychres.2016.02.052. Epub 2016 Feb 23. Psychiatry Res. 2016. PMID: 27137966
-
A review of the relationship between proinflammatory cytokines and major depressive disorder.
Young JJ, Bruno D, Pomara N. Young JJ, et al. J Affect Disord. 2014 Dec;169:15-20. doi: 10.1016/j.jad.2014.07.032. Epub 2014 Jul 30. J Affect Disord. 2014. PMID: 25128861 Review.
-
Cytokines: abnormalities in major depression and implications for pharmacological treatment.
O'Brien SM, Scott LV, Dinan TG. O'Brien SM, et al. Hum Psychopharmacol. 2004 Aug;19(6):397-403. doi: 10.1002/hup.609. Hum Psychopharmacol. 2004. PMID: 15303243 Review.
Cited by
-
Mood Disorders, Accelerated Aging, and Inflammation: Is the Link Hidden in Telomeres?
Squassina A, Pisanu C, Vanni R. Squassina A, et al. Cells. 2019 Jan 15;8(1):52. doi: 10.3390/cells8010052. Cells. 2019. PMID: 30650526 Free PMC article. Review.
-
Rachayon M, Jirakran K, Sodsai P, Sughondhabirom A, Maes M. Rachayon M, et al. Sci Rep. 2024 May 16;14(1):11177. doi: 10.1038/s41598-024-61865-y. Sci Rep. 2024. PMID: 38750122 Free PMC article.
-
Moudi S, Heidari B, Yousefghahari B, Gholami R, Gholinia H, Babaei M. Moudi S, et al. Reumatologia. 2023;61(2):86-91. doi: 10.5114/reum/154905. Epub 2023 Feb 1. Reumatologia. 2023. PMID: 37223374 Free PMC article.
-
Immune-based strategies for mood disorders: facts and challenges.
Colpo GD, Leboyer M, Dantzer R, Trivedi MH, Teixeira AL. Colpo GD, et al. Expert Rev Neurother. 2018 Feb;18(2):139-152. doi: 10.1080/14737175.2018.1407242. Epub 2017 Nov 27. Expert Rev Neurother. 2018. PMID: 29179585 Free PMC article. Review.
-
Zhan Y, Zhou Y, Zheng W, Liu W, Wang C, Lan X, Deng X, Xu Y, Zhang B, Ning Y. Zhan Y, et al. Transl Psychiatry. 2020 Jul 22;10(1):246. doi: 10.1038/s41398-020-00933-z. Transl Psychiatry. 2020. PMID: 32699226 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous